Evaluation of the effect of nano micelles containing curcumin (Sina Ccurcumin) as a therapeutic supplement in patients with COVID-19 and investigating of immune responses balance changes following treatment: A randomized double blind clinical trial.

Bandare-abbas University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新: 2020年7月13日

适应症

试验速览

暂无简介。

•Laboratory-approved COVID-19 tests (2019-nCoV Real-Time RT-PCR) (preferably at a particular center or university-approved center) regardless of clinical manifestations and close contact history
•Signing a written consent form
•No simultaneous participation in other clinical trials

•Pregnancy and lactation
•History of allergy to turmeric or curcumin products
•Smoking (more than 5 cigarettes a day)
•Patient connected to the ventilator
•Clinical evidence for respiratory failure at the time of hospitalization / admission (SaO2 = 90% or PaO2 <8 kPa)
•Having comorbidities (such as severe renal failure Glomerular filtration rate less than 30 ml / min, liver failure ,Congestive heart failure, or Chronic obstructive pulmonary disease)
•History of gallstones
•History of gastritis or active gastrointestinal ulcer

发起方

Bandare-abbas University of Medical Sciences